v3.10.0.1
Condensed Consolidated Balance Sheet (Unaudited) - USD ($)
Sep. 30, 2018
Dec. 31, 2017
Current Assets    
Cash $ 79,112 $ 110,792
Prepaid expenses 26,373 18,171
Accounts receivable 42,787
Inventory 242,135
Total Current Assets 390,407 128,963
Office equipment, net 5,256 1,323
Patents and trademarks, net 148,477 141,695
License Rights 489,151
TOTAL ASSETS 1,033,291 271,981
Current Liabilities    
Accounts payable and accrued expenses 535,267 141,931
Accounts payable and accrued expenses, related parties 445,397 220,012
Convertible notes payable, net of discounts 346,938 735,500
Notes payable 332,805 370,000
Note payable, related party 60,000 60,000
License fee payable 250,000
Derivative liabilities 1,002,530
Total Current Liabilities 2,972,937 1,527,443
Stockholders' Deficit    
Preferred stock (10,000,000 shares authorized, par value $0.001, no shares issued and outstanding)
Common stock (290,000,000 shares authorized par value $0.001, 28,076,301 and 13,000,000 shares issued and outstanding September 30, 2018 and December 31, 2017, respectively) 28,077 13,000
Deferred stock compensation (297,917)
Common stock to be issued (81,967 shares issuable September 30, 2018) 82
Additional paid in capital 1,363,953 291,155
Accumulated Deficit (3,024,943) (1,562,476)
Stock subscription receivable (7,600)
Accumulated comprehensive income (1,298) 2,859
Total Stockholders' Deficit (1,939,646) (1,255,462)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 1,033,291 $ 271,981

Source